Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 18
1964 29
1965 22
1966 18
1967 33
1968 30
1969 58
1970 53
1971 68
1972 65
1973 61
1974 80
1975 70
1976 87
1977 64
1978 96
1979 79
1980 84
1981 89
1982 118
1983 145
1984 171
1985 180
1986 173
1987 184
1988 311
1989 376
1990 482
1991 442
1992 518
1993 549
1994 617
1995 594
1996 602
1997 696
1998 596
1999 649
2000 710
2001 794
2002 964
2003 1011
2004 1094
2005 1011
2006 1028
2007 1065
2008 1016
2009 1048
2010 1230
2011 1301
2012 1336
2013 1433
2014 1611
2015 1665
2016 1753
2017 1630
2018 1570
2019 1439
2020 1794
2021 1824
2022 1863
2023 1834
2024 345

Text availability

Article attribute

Article type

Publication date

Search Results

37,911 results

Results by year

Filters applied: . Clear all
Page 1
Recent advances in the management of lung cancer.
Jones GS, Baldwin DR. Jones GS, et al. Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s41-s46. doi: 10.7861/clinmedicine.18-2-s41. Clin Med (Lond). 2018. PMID: 29700092 Free PMC article. Review.
Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review high …
Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important …
Lung Cancer.
Nasim F, Sabath BF, Eapen GA. Nasim F, et al. Med Clin North Am. 2019 May;103(3):463-473. doi: 10.1016/j.mcna.2018.12.006. Med Clin North Am. 2019. PMID: 30955514 Review.
Lung cancer is the world's leading cause of cancer death. Screening for lung cancer by low-dose computed tomography improves mortality. ...Treatment is determined by subtype and stage of cancer; there are several personalized therapies that did not exist just a few
Lung cancer is the world's leading cause of cancer death. Screening for lung cancer by low-dose computed tomography improves m
Multiple primary lung cancer: A literature review.
Romaszko AM, Doboszyńska A. Romaszko AM, et al. Adv Clin Exp Med. 2018 May;27(5):725-730. doi: 10.17219/acem/68631. Adv Clin Exp Med. 2018. PMID: 29790681 Free article. Review.
Nowadays, lung cancer is a leading cause of death in both men and women worldwide. ...However, it is already known that genetic and environmental factors as well as oncological treatment are involved. As the incidence of lung cancer soars, the number of patients dia …
Nowadays, lung cancer is a leading cause of death in both men and women worldwide. ...However, it is already known that genetic and e …
Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies.
Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Succony L, et al. Cancer Treat Rev. 2021 Sep;99:102237. doi: 10.1016/j.ctrv.2021.102237. Epub 2021 May 29. Cancer Treat Rev. 2021. PMID: 34182217 Review.
Adenocarcinoma has become the most prevalent lung cancer sub-type and its frequency is increasing. The earliest stages in the development of lung adenocarcinomas are visible using modern computed tomography (CT) as ground glass nodules. These pre-invasive nodules ca …
Adenocarcinoma has become the most prevalent lung cancer sub-type and its frequency is increasing. The earliest stages in the develop …
New insights into small-cell lung cancer development and therapy.
Wang Y, Zou S, Zhao Z, Liu P, Ke C, Xu S. Wang Y, et al. Cell Biol Int. 2020 Aug;44(8):1564-1576. doi: 10.1002/cbin.11359. Epub 2020 Apr 18. Cell Biol Int. 2020. PMID: 32281704 Free PMC article. Review.
Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases; however, it is characterized by easy relapse and low survival rate, leading to one of the most intractable diseases in clinical practice. ...
Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases; however, it is characterized by easy relaps …
Lung Cancer Staging.
Kutob L, Schneider F. Kutob L, et al. Surg Pathol Clin. 2020 Mar;13(1):57-71. doi: 10.1016/j.path.2019.10.003. Epub 2019 Dec 18. Surg Pathol Clin. 2020. PMID: 32005435 Review.
Lung cancer staging is a foundation of patient care, informing management decisions and prognosis. This comprehensive overview of the current 8th edition American Joint Committee on Cancer Cancer Staging Manual addresses common difficulties in staging, such as measuring th
Lung cancer staging is a foundation of patient care, informing management decisions and prognosis. This comprehensive overview of the
Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.
Pennell NA, Arcila ME, Gandara DR, West H. Pennell NA, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:531-542. doi: 10.1200/EDBK_237863. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099633 Free article. Review.
Over the last decade, the treatment of patients with advanced non-small cell lung cancer (NSCLC) has become reliant on tissue and/or blood biomarkers to help guide treatment decisions. ...
Over the last decade, the treatment of patients with advanced non-small cell lung cancer (NSCLC) has become reliant on tissue and/or …
Lung cancer.
Maghfoor I, Perry MC. Maghfoor I, et al. Ann Saudi Med. 2005 Jan-Feb;25(1):1-12. doi: 10.5144/0256-4947.2005.1. Ann Saudi Med. 2005. PMID: 15822487 Free PMC article. Review.
Lung cancer is the leading cause of cancer-related mortality. Since tobacco smoking is the cause in vast majority of cases, the incidence of lung cancer is expected to rise in those countries with high or rising incidence of tobacco smoking. Even though populations
Lung cancer is the leading cause of cancer-related mortality. Since tobacco smoking is the cause in vast majority of cases, the incid
Bronchioloalveolar carcinoma.
Arenberg D. Arenberg D. Semin Respir Crit Care Med. 2011 Feb;32(1):52-61. doi: 10.1055/s-0031-1272869. Epub 2011 Apr 15. Semin Respir Crit Care Med. 2011. PMID: 21500124 Review.
This review focuses on aspects of bronchioloalveolar carcinoma (BAC) in which it differs importantly from other forms of non-small-cell lung cancer. BAC is a form of adenocarcinoma with unique clinical, radiological, and epidemiological features. With the notable exception …
This review focuses on aspects of bronchioloalveolar carcinoma (BAC) in which it differs importantly from other forms of non-small-cell l
Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC).
Vergnenègre A, Chouaïd C. Vergnenègre A, et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):519-528. doi: 10.1080/14737167.2018.1485099. Epub 2018 Jun 14. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 29869900 Review.
INTRODUCTION: During the past few years, medical-economic evaluation of lung cancers (LCs) has become unavoidable. Total management costs have been rising constantly, with values almost doubling every 10 years. ...AREAS COVERED: This review provides an overview of the avai …
INTRODUCTION: During the past few years, medical-economic evaluation of lung cancers (LCs) has become unavoidable. Total management c …
37,911 results
You have reached the last available page of results. Please see the User Guide for more information.